B.Pharm

Government of Maharashtra, Rural Development Department Government Circular No. Miscellaneous 2022/P.No.11/Aastha-8, dt. 15th May 2023 as per the prescribed provisions and instructions under Zilla Parishad, Palghar for all cadres in Group-C (excluding the posts in Group-D cadre) to be filled by direct service from various departments outside the Scheduled Areas (Non-Pesa) and Government of Maharashtra, Government Decision of General Administration Department No. According to BCC 2018/Pro.No.427/16-B, dated February 01, 2023 Hon. Mr. Governor's D.

Tata Memorial Centre is an autonomous grant-in-aid institution of the Department of Atomic Energy. TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). ACTREC conducts a Ph.D. program in Life Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India). On-going research at ACTREC includes basic and translational research in Cancer Biology.

In continuation of the Vacancy Notice No.A-12024/3/2023/Recruitment Cell-DHS- HEALTH_AN /1633 dated 23.05.2023, the Andaman and Nicobar Health Department, Andaman and Nicobar Administration invites ONLINE APPLICATIONS for a further period of 20 (twenty) days with effect from 08.08.2023 at 12.00 PM to 27.08.2023 at 12.00 Midnight from the eligible candidates to fill up the following Group ‘B’ (Non-Gazettcd) Non-Ministerial and Group 'C’ Non Ministerial posts in the Pay Level in Pay Matrix as indicated against each.

Under the National Health Mission, Rajkot Corporation has announced to fill the following staff positions on temporary basis on contract basis for 11 months and to create a waiting list for the same

Post : Pharmacist (RBSK)

No of posts : 03

Maharashtra Government Rural Development Department Government Decision No. Miscellaneous-2022/P.No.11/Aastha-8 Dated 15 November 2022, Government of Maharashtra General Administration Department Government Decision No. Pranim 1222/P.No. 136/Ka-13 A dated 21 November 2022, Government of Maharashtra, General Administration Department Government Decision no. BCC 2018/Pro.No.427/16-B, dt. 10th May, 2023, Government of Maharashtra, Rural Development Department Government Circular No. Miscellaneous 2022/P.No.11/Aastha-8, dt.

Maharashtra Government Rural Development Department Government Decision No. Miscellaneous-2022/P.No.11/Aastha-8 Dated 15 November 2022, Government of Maharashtra General Administration Department Government Decision No. 1222/P.No. 136/Ka- 13B dated 21 November 2022, Government of Maharashtra, General Administration Department Government Decision No. BCC 2018/Pro.No.427/16-B, dt. 10th May, 2023, Government of Maharashtra, Rural Development Department Government Circular No. - Miscellaneous 2022/P.No.11 /Aastha-8, dt.

Maharashtra Government Rural Development Department Government Decision No. Miscellaneous-2022/P.No.11/Aastha-8 Dated 15 November 2022, Government of Maharashtra General Administration Department Government Decision No. 1222/P.No. 136/Ka-13B dated 21 November 2022, Government of Maharashtra, General Administration Department Government Decision no. BCC 2018/Q.No. 427/16-B, dt. 10th May, 2023, Government of Maharashtra Rural Development Department Government Circular No.- Miscellaneous 2022/ P.No. 11/Aastha-8, dt.

Established in 2016, ANNORA Pharma is committed to provide medicines with highest quality, safety and efficacy that meets the needs of the customers with applicable statutory and regulatory requirements.  Spread over in thirty-five acres land, our manufacturing facility close to the city of Hyderabad, India specializes in manufacturing of Tablets, Capsules, Pellets, Liquid Orals, Suppositories and Dry Powder Syrups catering to a diverse therapeutic range.

In pharmaceutical vertical, the family has two companies – Windlas Biotech Limited (WBL) and Windlas Healthcare Private Limited (WHC). WBL was founded in year 2000 with and provides contract manufacturing services for the Indian pharma market, employing over 400 staff and workers, and has a revenue of about Rs. 80 crores in the last fiscal (FY ‘08-’09). WBL also promotes its own branded generic products in India with a small sales team of 180 people.